Immuno-genetic screening to improve cancer therapies and developing novel antibody drugs 1-10 Employees
- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
Svastia Genetics Funding
$150K
11 round
500 Global
Svastia Genetics is active in the following markets / industries: health care, pharmaceuticals, clinical trials and Contract Research Organizations. The company has secured funding across 1 rounds, totaling in an amount of $150K. Their most recent funding was raised on February 1, 2019.
Funding Rounds
PRE
$150000Pre-SeedFeb 2019
Investors of Svastia Genetics
500 Global is a venture capital firm that has invested in 2500+ cos across 77 countries
Rounds
PRE